South Africa’s medical aid market is under fresh scrutiny for a pattern that clinicians and members know too well. This has prompted renewed discussion about value-based healthcare and its potential to improve patient outcomes and system sustainability. Schemes routinely fund high-cost, late-stage interventions. Yet they often resist paying for prevention and side-effect management that could avoid hospital admissions later. This…
Tag: PMBs
-
GLP-1 Weight Loss Drugs Reshape Obesity Care In South Africa
South Africa’s fight against obesity has entered a decisive phase, driven by a surge in the medicalisation of treatment through GLP-1 weight loss drugs. In early 2026, two major medications, Mounjaro (tirzepatide) and Wegovy (semaglutide), have received key regulatory approvals, marking a new chapter in primary healthcare. With nearly 4.5 million South African adults living with obesity, the shift comes…